Sustainability
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Frontera TherapeuticsChina - Suzhou
1 programSustainability of Laparoscopic Appendectomy. Variability of Determining Factors.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
Human BioSciencesBiweekly monitoring and feedback
Frontera TherapeuticsSustainability of Laparoscopic Appendectomy. Variability of Determining Factors.
Clinical Trials (2)
Total enrollment: 3,768 patients across 2 trials
Sustainability and Precision Prevention Project
Start: Oct 2025Est. completion: Nov 20293,705 patients
N/ARecruiting
NCT07457853Frontera TherapeuticsSustainability of Laparoscopic Appendectomy. Variability of Determining Factors.
Sustainability of Laparoscopic Appendectomy. Variability of Determining Factors.
Start: Aug 2024Est. completion: Oct 202563 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 3,768 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.